Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Molecular Diagnostics » Yourgene Health Acquiring French Distributor of NIPT Test for up to €4.1M

Yourgene Health Acquiring French Distributor of NIPT Test for up to €4.1M

Mar 10, 2020
|
staff reporter

NEW YORK – Yourgene Health said on Tuesday that it is acquiring AGX-DPNI, its current distribution partner for its Iona noninvasive prenatal test in France, for €2.4 million ($2.7 million) in cash and up to €1.7 million in cash earn-out payments based on sales growth performance.

AGX-DPNI is a newly formed entity that consists of the NIPT distribution business of AdGeniX, a privately held company based near Versailles that sells cytogenetic and pharmaceutical laboratory products.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

A Start

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

Just Go 'Round the CDC

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

Student Visa Directive Rescinded

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

Cell Studies on Blood Features of Severe COVID-19 Cases, Infection-Related Phosphorylation Shifts, More

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.

Jul
22
Featured Webinar

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Sponsored by
Thermo Fisher Scientific

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

Sponsored by
Roche

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Aug
25
Featured Webinar

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

Sponsored by
Roche

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.

Aug
27
Featured Webinar

CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

Sponsored by
Cellecta

Over 70 percent of breast cancers are estrogen receptor positive and are treated with endocrine therapy.

What's Popular?

In Molecular Diagnostics

  1. Helix, San Diego County Partner on COVID-19 Molecular Testing

  2. Sema4 Nabs New York State Approval for Cancer Somatic Sequencing Tests

  3. SARS-CoV-2 Pandemic May Promote Progress in Paper MDx

  4. Canadian Consortium Launches C$2.6M Liquid Biopsy Initiative to Improve Targeted Cancer Treatment

  5. Thermo Fisher Scientific, First Genetics to Develop NGS-Based Diagnostics in Russia

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.